213 related articles for article (PubMed ID: 25915942)
1. MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA.
Tombolan L; Zampini M; Casara S; Boldrin E; Zin A; Bisogno G; Rosolen A; De Pittà C; Lanfranchi G
PLoS One; 2015; 10(4):e0125171. PubMed ID: 25915942
[TBL] [Abstract][Full Text] [Related]
2. Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members.
Megiorni F; Cialfi S; McDowell HP; Felsani A; Camero S; Guffanti A; Pizer B; Clerico A; De Grazia A; Pizzuti A; Moles A; Dominici C
BMC Cancer; 2014 Nov; 14():880. PubMed ID: 25427715
[TBL] [Abstract][Full Text] [Related]
3. Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors.
Makawita S; Ho M; Durbin AD; Thorner PS; Malkin D; Somers GR
Pediatr Dev Pathol; 2009; 12(2):127-35. PubMed ID: 18788888
[TBL] [Abstract][Full Text] [Related]
4. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
[TBL] [Abstract][Full Text] [Related]
5. Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.
Tombolan L; Poli E; Martini P; Zin A; Millino C; Pacchioni B; Celegato B; Bisogno G; Romualdi C; Rosolen A; Lanfranchi G
BMC Cancer; 2016 Nov; 16(1):886. PubMed ID: 27842508
[TBL] [Abstract][Full Text] [Related]
6. PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma.
Hanna JA; Garcia MR; Go JC; Finkelstein D; Kodali K; Pagala V; Wang X; Peng J; Hatley ME
Cell Death Dis; 2016 Jun; 7(6):e2256. PubMed ID: 27277678
[TBL] [Abstract][Full Text] [Related]
7. Autoregulatory loop between TGF-β1/miR-411-5p/SPRY4 and MAPK pathway in rhabdomyosarcoma modulates proliferation and differentiation.
Sun M; Huang F; Yu D; Zhang Y; Xu H; Zhang L; Li L; Dong L; Guo L; Wang S
Cell Death Dis; 2015 Aug; 6(8):e1859. PubMed ID: 26291313
[TBL] [Abstract][Full Text] [Related]
8. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
[TBL] [Abstract][Full Text] [Related]
9. MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor γ.
Li S; Li J; Fei BY; Shao D; Pan Y; Mo ZH; Sun BZ; Zhang D; Zheng X; Zhang M; Zhang XW; Chen L
Chin Med J (Engl); 2015 Apr; 128(7):941-7. PubMed ID: 25836616
[TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
Skrzypek K; Kusienicka A; Szewczyk B; Adamus T; Lukasiewicz E; Miekus K; Majka M
Oncotarget; 2015 Oct; 6(31):31378-98. PubMed ID: 26384300
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of rhabdomyosarcoma cell lines using retinoic acid.
Barlow JW; Wiley JC; Mous M; Narendran A; Gee MF; Goldberg M; Sexsmith E; Malkin D
Pediatr Blood Cancer; 2006 Nov; 47(6):773-84. PubMed ID: 16283617
[TBL] [Abstract][Full Text] [Related]
12. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation.
Taulli R; Bersani F; Foglizzo V; Linari A; Vigna E; Ladanyi M; Tuschl T; Ponzetto C
J Clin Invest; 2009 Aug; 119(8):2366-78. PubMed ID: 19620785
[TBL] [Abstract][Full Text] [Related]
13. miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro.
Miao Y; Li J; Qiu X; Li Y; Wang Z; Luan Y
Oncol Rep; 2013 Jan; 29(1):161-8. PubMed ID: 23117485
[TBL] [Abstract][Full Text] [Related]
14. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M
J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488
[TBL] [Abstract][Full Text] [Related]
15. Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodeling complex contributes to the differentiation block in rhabdomyosarcoma.
Taulli R; Foglizzo V; Morena D; Coda DM; Ala U; Bersani F; Maestro N; Ponzetto C
Oncogene; 2014 May; 33(18):2354-62. PubMed ID: 23728344
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid.
Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D
Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-138 promotes tau phosphorylation by targeting retinoic acid receptor alpha.
Wang X; Tan L; Lu Y; Peng J; Zhu Y; Zhang Y; Sun Z
FEBS Lett; 2015 Mar; 589(6):726-9. PubMed ID: 25680531
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays.
Carey KA; Segal D; Klein R; Sanigorski A; Walder K; Collier GR; Cameron-Smith D
Pathol Int; 2006 May; 56(5):246-55. PubMed ID: 16669873
[TBL] [Abstract][Full Text] [Related]
19. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
[TBL] [Abstract][Full Text] [Related]
20. Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma.
Miyachi M; Tsuchiya K; Yoshida H; Yagyu S; Kikuchi K; Misawa A; Iehara T; Hosoi H
Biochem Biophys Res Commun; 2010 Sep; 400(1):89-93. PubMed ID: 20696132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]